drugset / Trial / NCT06614010
Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
To examine the impact of various administration routes of dexmedetomidine in conjunction with ultrasound-guided fascia iliaca block (FIB) on emergence agitation (EA) during the postoperative recovery period after hip replacement surgery.
Timeline
- Start
- 2023-02-05
- Primary completion
- 2025-09-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intravenous |
| Background | Ropivacaine | Other / unclassified | 0.375 % | Other |
| Background | Ropivacaine | Other / unclassified | 30 ml | Other |
Indications
No indication recorded.